Richard Maidman


I engage with my clients to provide creative solutions to complex disputes and distill complicated facts into persuasive arguments.

Richard Maidman litigates disputes and intellectual property suits as a member of the firm’s International Litigation & Arbitration and Intellectual Property practices.

In his disputes practice, Richard represents States and private and State-owned entities in commercial and investment treaty disputes before arbitral tribunals under various governing rules. He has represented clients in disputes ranging from intellectual property to construction, energy pricing and supply, power purchase agreements and environmental cleanup, among others. Richard also represents foreign sovereigns and state instrumentalities in U.S. courts.

Richard’s intellectual property practice focuses on representing clients in patent infringement lawsuits across a range of industries, including biotechnology, pharmaceuticals, and consumer products. Richard also has experience litigating patent cases brought under the Hatch-Waxman Act, and he has represented clients in commercial disputes relating to licensing, drug development, and product safety.


  • University of Michigan Law School, J.D., magna cum laude, Order of the Coif, 2011
  • Northwestern University, B.A., 2008

Bar and Court Admissions

  • New York
  • Massachusetts
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York


  • Represented Becton, Dickinson and Company and the University of California in a patent infringement litigation asserting multiple patents covering polymer dyes and their use in flow cytometry, resulting in the negotiation of a favorable settlement just before trial
  • Defended Biogen in a breach of contract and trade secret suit regarding ownership rights under a collaboration agreement to develop small molecule inhibitors of Bruton’s Tyrosine Kinase.  Obtained dismissal of all claims with prejudice
  • Represented multiple pharmaceutical companies in patent litigation under the Hatch-Waxman Act. Drug products that were the subject of these litigations include protease inhibitors (HIV), triptans (migraine), and statins (cholesterol)
  • Represents nutritional supplement company in patent litigation against competitor
  • Represented consumer products company in patent litigation concerning pool floats
  • Chevron Corp. & Texaco Petroleum Corp. v. Republic of Ecuador. Representing Ecuador in an UNCITRAL Rules arbitration brought pursuant to an investment treaty regarding a $9.5 billion judgment issued by an Ecuadorian court against Chevron for pollution and human health damages in the Ecuadorian Amazon
  • Counsel to entity in ICC arbitration involving a large-scale solar power project
  • Counsel to an Asian state-owned entity in an UNCITRAL arbitration administered by SIAC arising from drilling and exploration agreements of natural gas reserves
  • Counsel to an Asian state-owned entity in an UNCITRAL arbitration arising from a change in gas market fundamentals
  • Counsel to an Asian entity in lawsuit in the United States District Court for the Southern District of New York regarding telecommunications network
  • Counsel to State in UNCITRAL arbitration regarding trademarks

Honors & Involvement

  • Selected by his peers for inclusion in US News & World Report/Best Lawyers: Ones to Watch in Litigation - Intellectual Property (2022) 
  • Contributing Editor, Michigan Law Review
  • American Intellectual Property Law Association, Member
  • Boston Bar Association, Member